| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $531.1M | +43.7% |
| Cost of Revenue | $142.1M | +42.9% |
| Gross Profit | $389.0M | +44.0% |
| R&D Expense | $194.4M | +29.2% |
| SG&A Expense | $132.1M | +12.1% |
| Operating Income | -$13.3M | +79.7% |
| Pre-tax Income | $17.8M | +130.3% |
| Income Tax | $1.7M | +82.3% |
| Net Income | $16.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $747.6M | +22.9% |
| Accounts Receivable | $89.0M | +90.4% |
| Current Assets | $897.8M | +28.8% |
| Total Assets | $954.0M | +27.6% |
| Current Liabilities | $277.4M | +52.6% |
| Total Liabilities | $298.5M | +45.4% |
| Stockholders' Equity | $655.5M | +20.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $153.6M | +186.3% |
| Capital Expenditures | $3.2M | -42.6% |
| Investing Cash Flow | -$13.6M | +4.2% |
| Financing Cash Flow | $2.1M | -85.6% |
| Free Cash Flow | $150.4M | +212.8% |
| +127.0% |
| EPS (Basic) | $0.39 | +125.8% |
| EPS (Diluted) | $0.35 | +123.2% |